SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-23-023002
Filing Date
2023-03-27
Accepted
2023-03-27 10:33:10
Documents
162

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO FORM F-1 ea175730-f1a6_altamira.htm   iXBRL F-1/A 3725629
2 FORM OF AMENDMENT NO. 4 TO CONVERTIBLE LOAN AGREEMENT, BETWEEN ALTAMIRA THERAPEU ea175730ex10-23_altamira.htm EX-10.23 10661
3 CONSENT OF DELOITTE AG ea175730ex23-1_altamira.htm EX-23.1 2308
4 GRAPHIC image_001.jpg GRAPHIC 3988
  Complete submission text file 0001213900-23-023002.txt   15251167

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cyto-20220630.xsd EX-101.SCH 240138
6 XBRL CALCULATION FILE cyto-20220630_cal.xml EX-101.CAL 43192
7 XBRL DEFINITION FILE cyto-20220630_def.xml EX-101.DEF 566991
8 XBRL LABEL FILE cyto-20220630_lab.xml EX-101.LAB 1160865
9 XBRL PRESENTATION FILE cyto-20220630_pre.xml EX-101.PRE 604096
156 EXTRACTED XBRL INSTANCE DOCUMENT ea175730-f1a6_altamira_htm.xml XML 2634189
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-269823 | Film No.: 23761852
SIC: 2834 Pharmaceutical Preparations